PolarityTE Announces Entry Into a Letter of Intent For Acquisition of the Company
/PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing regenerative tissue products and biomaterials (the "Company"), today...
PolarityTE Reports Third Quarter 2022 Financial Results and Provides Business Update
/PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE) a biotechnology company developing regenerative tissue products and biomaterials, today provided a business...
PolarityTE Confirms Receipt of Unsolicited, Non-Binding Offer to Acquire the Company
/PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing regenerative tissue products and biomaterials, today confirmed that on...
PolarityTE Reports Second Quarter 2022 Financial Results and Provides Business Update
/PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE) a biotechnology company developing regenerative tissue products and biomaterials, today provided a business...